Ensign Peak Advisors
IDYA icon

Ensign Peak Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Ensign Peak Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.96M Sell
267,182
-632,322
-70% -$19.4M 0.02% 439
2026
Q1 		$30M Sell
899,504
-79,559
-8% -$2.67M 0.06% 251
2025
Q4 		$33.8M Buy
979,063
+225,899
+30% +$7.2M 0.06% 230
2025
Q3 		$20.5M Buy
753,164
+11,331
+2% +$274K 0.03% 305
2025
Q2 		$15.6M Buy
741,833
+414,189
+126% +$7.95M 0.03% 372
2025
Q1 		$5.37M Sell
327,644
-236,573
-42% -$5.04M 0.01% 614
2024
Q4 		$14.5M Sell
564,217
-47,597
-8% -$1.35M 0.03% 382
2024
Q3 		$19.4M Buy
611,814
+128,100
+26% +$4.86M 0.03% 333
2024
Q2 		$17M Sell
483,714
-4,656
-1% -$184K 0.03% 336
2024
Q1 		$21.4M Sell
488,370
-1,669
-0.3% -$71.8K 0.04% 312
2023
Q4 		$17.4M Buy
490,039
+126,255
+35% +$3.77M 0.03% 321
2023
Q3 		$9.81M Buy
363,784
+130,350
+56% +$3.31M 0.02% 396
2023
Q2 		$5.49M Buy
233,434
+141,023
+153% +$2.9M 0.01% 559
2023
Q1 		$1.27M Hold
92,411
– – ﹤0.01% 1059
2022
Q4 		$1.68M Sell
92,411
-7,760
-8% -$131K ﹤0.01% 880
2022
Q3 		$1.5M Buy
100,171
+5,390
+6% +$70K ﹤0.01% 890
2022
Q2 		$1.31M Hold
94,781
– – ﹤0.01% 995
2022
Q1 		$1.06M Buy
94,781
+2,370
+3% +$34.9K ﹤0.01% 1164
2021
Q4 		$2.19M Buy
92,411
+55,496
+150% +$1.29M ﹤0.01% 925
2021
Q3 		$941K Hold
36,915
– – ﹤0.01% 1460
2021
Q2 		$775K Hold
36,915
– – ﹤0.01% 1501
2021
Q1 		$868K Hold
36,915
– – ﹤0.01% 1468
2020
Q4 		$517K Hold
36,915
– – ﹤0.01% 1598
2020
Q3 		$464K Buy
+36,915
New +$457K ﹤0.01% 1548

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Ensign Peak Advisors's IDYA Position: Q2 2026 in Review

Ensign Peak Advisors reduced its IDEAYA Biosciences (IDYA) stake by 70% in Q2 2026, selling an estimated $19.4M and leaving 267,182 shares worth $9.96M. The position accounts for 0.02% of the portfolio, ranked #439.

Ensign Peak Advisors first reported a position in IDYA in Q3 2020 and has held it in 24 quarters since. The position peaked at $33.8M in Q4 2025. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Ensign Peak Advisors held 267,182 shares of IDEAYA Biosciences worth $9.96M as of Q2 2026.
  • Ensign Peak Advisors sold 632,322 IDEAYA Biosciences shares in Q2 2026, an estimated $19.4M.
  • IDEAYA Biosciences made up 0.02% of Ensign Peak Advisors's portfolio in Q2 2026, its #439 holding.
  • Ensign Peak Advisors first reported a position in IDEAYA Biosciences in Q3 2020 and has held it in 24 quarters since.
  • Ensign Peak Advisors's IDEAYA Biosciences position peaked at $33.8M in Q4 2025.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.